Skip to content
★ Sign in to follow
LL

Liesel Loesch

Vantagemed Corp
Total declarations
4
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 20 Apr 2007 for VANTAGEMED CORP, €17k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Liesel Loesch: trading record in brief

This profile gathers the share dealings of Liesel Loesch in Vantagemed Corp. Activity is concentrated on a single trading day, 18 April 2007, with 4 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Most recently, on 23 April 2007, the filings show an option exercise worth €4,404 in Vantagemed Corp. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Liesel Loesch

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ●
    Chief Financial OfficerExecutivesVantagemed Corp
    22,500 USD0SEC
    30,000 shares@ US$0.75vantagemed common stockSEC:0001179110-07-008134:0
  • ◇
    Chief Financial OfficerExecutivesVantagemed Corp
    6,000 USD0SEC
    30,000 shares@ US$0.20vantagemed common stockSEC:0001179110-07-008134:1

2 of 2 declarations